Lipoprotein A Levels in Pediatric Migraine


TEBER S., BEKTAŞ Ö., Yilmaz A., Aksoy E., Akar N., Deda G.

PEDIATRIC NEUROLOGY, cilt.45, sa.4, ss.225-228, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 4
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1016/j.pediatrneurol.2011.06.008
  • Dergi Adı: PEDIATRIC NEUROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.225-228
  • Ankara Üniversitesi Adresli: Evet

Özet

The purpose of this study was to examine the lipoprotein (a) [Lp(a)] levels in children with migraine to see a possible relationship between migraine and stroke via high Lp(a) levels. Plasma levels of Lp(a) were determined in 63 patients and age-matched control subjects. The mean age in the control group was 10.57 +/- 3.63 years and 11.51 +/- 3.19 years in the migraine patient group. The mean Lp(a) levels in control group were 10.36 +/- 10.41 ng/mL and 17.09 +/- 12.12 ng/mL in migraine group (P < 0.05). The median Lp(a) level in the control group was 49.38 ng/mL and was 77.62 ng/mL in the migraine group (P < 0.05). Twelve patients (19%) had Lp(a) levels of >30 ng/mL in the migraine group and 4 (6.3%) in the control group (P < 0.05). Several prothrombotic factors related to an increased risk of stroke have been studied in migraine patients. It has recently been reported that high Lp(a) concentrations represent a risk factor for migraine, thus establishing a novel plausible link between migraine and stroke. The current study suggests evidence of high Lp(a) concentrations in childhood migraine; perhaps a novel link exists between migraine and stroke. Crown Copyright (C) 2011 Published by Elsevier Inc. All rights reserved.